Trials / Sponsors / Klus Pharma Inc.
Klus Pharma Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small C Non-small Cell Lung Cancer | Phase 2 | 2023-04-19 |
| Active Not Recruiting | SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors Solid Tumor | Phase 2 | 2023-01-17 |
| Active Not Recruiting | Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (K Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 1 / Phase 2 | 2020-02-28 |
| Completed | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Ge HER2-positive Breast Cancer, HER2 Gene Mutation, HER-2 Gene Amplification | Phase 1 / Phase 2 | 2018-07-16 |